Primate Promoters: Sequencing Reveals How Our DNA Regulation Differs From Apes’
Humans, chimps and monkeys have strikingly similar genomes. This data helps us understand differences across these primate species. It displays information about DNA segments that regulate genes in one small part of the human and chimp genomes, aligned for comparative purposes. There are 3 "lines" of data for each species, with the top line in each (red for human, green for chimp) reflecting the conclusion that in this genomic space, gene enhancer activity in unactivated T-cells is very similar, with one exception: the yellow "peak" (arrows) indicates a likely gene enhancer that's active in human but inactive in chimp. Credit: Cold Spring Harbor Laboratory
We share 99% of our genes with great apes, but greatly differ from them. A new study has used state-of-the-art sequencing technology to explain exactly why that is. The new evidence has to do with the way genes are regulated. It’s the result of a comprehensive genome-wide computational analysis of multiple individuals across three primate species—human, chimpanzee and rhesus macaque.
The researchers focused on regulatory DNA elements called gene enhancers and promoters. Promoters sit immediately “upstream” of genes and must be activated for the genes they regulate to be switched on. Less is known about enhancers, which can be located varying distances up- and downstream of the genes they regulate. Enhancers can be much farther away from the “gene body” than promoters but can come close to the gene because of the looping shape of chromatin, the structure that packages the genome. Often, multiple enhancers are involved in a given gene’s activation, in combinations that differ under differing circumstances.
Professor Adam Siepel’s team at Cold Spring Harbor Laboratory (CSHL) with colleagues at Cornell University led by Dr. Charles Danko, used a technology called PRO-Seq to measure nascent transcription—the generation of RNA copies of genomic DNA up- and downstream of genes. It enables researchers to detect which promoters and enhancers are actively regulating a gene. They studied a single cell type, CD4+ T cells of the immune system, comparing levels of RNA copying when the cells were in quiescent and activated states in the three primate species.
The experiments revealed that while the activity of genes across the three species was quite similar in the CD4+ T cells, there were intriguing differences in the way genes were regulated. The team paid particular attention to collections of enhancers that jointly influence the expression of a target gene, as an ensemble. “These ensembles come in various sizes,” Siepel explains, “and we found that when they are large, the expression levels of the target genes tend to be stable over evolutionary time. When they are small, the expression levels are less stable.” Stability in gene expression is evidence of what scientists call evolutionary conservation—the preservation of a feature across species because of the advantage it confers.
Through careful analysis, the team identified various features that distinguish fast-evolving enhancers from slower ones. “Particularly interesting to us were cases in which large numbers of enhancers together determine the expression of a target gene,” says Siepel, who is Director of the Simons Center for Quantitative Biology at CSHL. “In these cases, the genes tend to be more stable, but we found each individual enhancer is more likely to change.” What’s under evolutionary selection is the target expression level of a given gene, which in these situations is jointly determined by the whole ensemble.
The research reveals how programs for gene expression change during evolution, leading to the differences in behavior and morphology we observe between humans and other primates. These evolutionary mysteries also offer clues about mutations that cause diseases by altering gene regulation, Siepel notes.
Mechanism Controlling Multiple Sclerosis Risk IdentifiedNews
Researchers at Karolinska Institutet have now discovered a new mechanism of a major risk gene for multiple sclerosis (MS) that triggers disease through so-called epigenetic regulation. They also found a protective genetic variant that reduces the risk for MS through the same mechanism.
Synthetic DNA Shuffling Enzyme Outpaces Natural CounterpartNews
A new synthetic enzyme, crafted from DNA rather than protein, flips lipid molecules within the cell membrane, triggering a signal pathway that could be harnessed to induce cell death in cancer cells. Researchers say their lipid-scrambling DNA enzyme is the first in its class to outperform naturally occurring enzymes – and does so by three orders of magnitudeREAD MORE
Antarctic Worm and Machine Learning Help Identify Cerebral Palsy EarlierNews
A research team has released a study in the peer-reviewed journal BMC Bioinformatics showing that DNA methylation patterns in circulating blood cells can be used to help identify spastic cerebral palsy (CP) patients. The technique which makes use of machine learning, data science and even analysis of Antarctic worms, raises hopes for earlier targeted CP therapies.